Adipogenesis and Insulin Resistance
Adipogenesis and Insulin Resistance
批准号:
8349647
负责人:
Arthur Sherman
金额:
$8.02万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AdipocytesAdipose tissueAnimal ModelAnimalsCell Differentiation processCell SizeCellsCharacteristicsCollaborationsDefectDepositionDiabetes MellitusDiseaseExhibitsExtramural ActivitiesFailureFatty acid glycerol estersFiltrationFirst Degree RelativeFunctional disorderGenesGoalsHyperplasiaHypertrophyImpairmentIndividualInflammatoryInsulinInsulin ResistanceInterleukin-6LeadLiverMetabolicModelingMuscleMutationNational Institute of Diabetes and Digestive and Kidney DiseasesNatureNon-Insulin-Dependent Diabetes MellitusNylonsObesityOrganOverweightPancreasPaperPathogenesisPeroxisome Proliferator-Activated ReceptorsPilot ProjectsPioglitazonePreparationProcessPropertyRattusRecording of previous eventsRecruitment ActivityReportingResistanceRisk FactorsRoleTailTestingTimeWorkadipocyte differentiationadiponectindiabeticglucose uptakeinsulin sensitizing drugslipid biosynthesisresponserosiglitazone
中文摘要
我们继续与库什曼实验室(NIDDK)和几个校外实验室合作,分析脂肪组织中的细胞大小分布,以阐明脂肪细胞大小与胰岛素抵抗之间的关系。我们以前报道过这种分布大致是双模型的,大的成熟细胞有高斯峰,小细胞有指数尾。与先前的假设相反,当适度肥胖的受试者与肥胖相匹配时,我们无法发现大脂肪细胞本身的大小与胰岛素抵抗(IR)之间的关联。相反,我们发现大细胞的比例与IR之间存在相关性,抵抗性受试者的大细胞不足。我们提出,这反映了脂肪细胞分化的损害,导致脂肪储存能力不足和脂肪异位沉积在其他器官,如肝脏、胰腺和肌肉,这些器官不具备处理大量脂肪的能力。对这些问题进行的重新分析,涉及更大范围的BMI范围,证实了小细胞比例与IR之间的相关性,但也显示了大细胞大小与IR之间的相关性。在早期的初步研究中,我们将未能观察到这一点归因于BMI限制范围内的受试者人数较少。一篇论文正在准备中。
英文摘要
We continue our collaboration with the Cushman lab (NIDDK) and several extramural labs to analyze cell-size distributions in adipose tissue in order to elucidate relationships between fat cell size and insulin resistance. We previously reported that such distributions are roughly bi-model, with a Gaussian peak of large, mature cells and an exponential tail of small cells. In contrast to prior hypotheses, we were unable to find an association between the size of the large fat cells per se and insulin resistance (IR) when moderately obese subjects are matched for obesity. Rather, we found a correlation between the proportion of large cells and IR, with resistant subjects having a deficit of large cells. We proposed that this reflects an impairment of adipocyte differentiation and leads to insufficient fat storage capacity and ectopic fat deposition in other organs, such as liver, pancreas, and muscle, that are not well equipped to handle large volumes of fat. A reanalysis of these questions with a much larger group of subjects spanning a much wider range of BMI has confirmed the correlation between the proportion of small cells and IR but also showed a correlation between large cell size and IR. We attribute the failure to observe this in the earlier pilot study to the smallnumber of subjects the restricted range of BMI. A paper is in preparation.
In collaboration with the Smith lab (Gothenburg) we have found a correlation between the size of the large cells and IR in a group of leaner, younger subjects who were first degree relatives of type 2 diabetics (paper in revision). We suggest that this is because the leaner subjects are still able to expand their adipose cells whereas the more obese subjects have reached the limit of cell expansion (hypertrophy) and must recruit new cells (hyperplasia). Furthermore, administration of insulin-sensitizing drugs, such as pioglitazone or rosiglitazone, leads to both recruitment of new cells, which increases the proportion of small cells, and expansion of existing large cells (paper in preparation). Thus, in all these cases the distribution of adipose cell sizes is related to metabolic status, but the particular response is dependent on the metabolic status and history of the subject. Considering these results together with those from the Stanford group (previous paragraph) and work in other sections of LBM, we conclude that large cell size is a primary risk factor for insulin resistance, along with an excess of small cells, reflecting impaired differentiation. Indeed, the two properties may be related, as a defect in potential to recruit and enlarge new adipocytes may be compensated by enlargement of existing adipocytes beyond their healthy operating range.
In collaboration with the McLaughlin lab (Stanford) we have also tested the hypothesis that small adipocytes per se are subject to impaired differentiation and function. Small adipocytes were isolated from epididymal adipose tissue of Zucker Obese (ZO) and Lean (ZL) rats and separated by sequential filtration through nylon meshes. Using quantitative real-time PCR for cell differentiation and inflammatory genes we found that the small cels represented a greater proportion in ZO than ZL rats. The small cells in the ZO rats had decreased adiponectin, and increased visfatin and IL-6 levels. The small adipocytes in the ZO rats also had lower adiponectin and PPARγ levels than in the ZL rats but increased IL-6. We thus confirmed for these animal models that the small adipocytes exhibited impaired cell differentiation and pro-inflammatory activity in addition to being present in higher proportions. We suggest that these properties contribute to insulin resistance in the animals. See Ref. # 1.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mathematical Modeling of Neurons and Endocrine Cells
-
批准号:8553369
-
项目类别:
-
资助金额:$12.42万
-
财政年份:--
-
负责人:Arthur Sherman
-
依托单位:
Mathematical Modeling of Neurons and Endocrine Cells
-
批准号:10008647
-
项目类别:
-
资助金额:$19.66万
-
财政年份:--
-
负责人:Arthur Sherman
-
依托单位:
Adipogenesis and Insulin Resistance
-
批准号:8148667
-
项目类别:
-
资助金额:$8.9万
-
财政年份:--
-
负责人:Arthur Sherman
-
依托单位:
Molecular modeling of G protein-coupled receptors
-
批准号:8553366
-
项目类别:
-
资助金额:$6.21万
-
财政年份:--
-
负责人:Arthur Sherman
-
依托单位:
Adipogenesis and Insulin Resistance
-
批准号:9553212
-
项目类别:
-
资助金额:$3.96万
-
财政年份:--
-
负责人:Arthur Sherman
-
依托单位:
Mathematical Modeling of Neurons and Endocrine Cells
-
批准号:8741340
-
项目类别:
-
资助金额:$6.23万
-
财政年份:--
-
负责人:Arthur Sherman
-
依托单位:
Stimulus secretion coupling in pancreatic beta-cells
-
批准号:8349645
-
项目类别:
-
资助金额:$24.06万
-
财政年份:--
-
负责人:Arthur Sherman
-
依托单位:
Adipogenesis and Insulin Resistance
-
批准号:8741341
-
项目类别:
-
资助金额:$3.12万
-
财政年份:--
-
负责人:Arthur Sherman
-
依托单位:
Stimulus secretion coupling in pancreatic beta-cells
-
批准号:7593401
-
项目类别:
-
资助金额:$42.61万
-
财政年份:--
-
负责人:Arthur Sherman
-
依托单位:
Stimulus secretion coupling in pancreatic beta-cells
-
批准号:9356042
-
项目类别:
-
资助金额:$18.06万
-
财政年份:--
-
负责人:Arthur Sherman
-
依托单位:
Mathematical Modeling of Neurons and Endocrine Cells
-
批准号:8939485
-
项目类别:
-
资助金额:$5.64万
-
财政年份:--
-
负责人:Arthur Sherman
-
依托单位:
Mathematical Modeling of Neurons and Endocrine Cells
-
批准号:7967139
-
项目类别:
-
资助金额:$15.18万
-
财政年份:--
-
负责人:Arthur Sherman
-
依托单位:
Stimulus secretion coupling in pancreatic beta-cells
-
批准号:7967137
-
项目类别:
-
资助金额:$45.55万
-
财政年份:--
-
负责人:Arthur Sherman
-
依托单位:
Adipogenesis and Insulin Resistance
-
批准号:7967141
-
项目类别:
-
资助金额:$15.18万
-
财政年份:--
-
负责人:Arthur Sherman
-
依托单位:
Mathematical Modeling of Neurons and Endocrine Cells
-
批准号:10697713
-
项目类别:
-
资助金额:$2.55万
-
财政年份:--
-
负责人:Arthur Sherman
-
依托单位:
Stimulus secretion coupling in pancreatic beta-cells
-
批准号:8553368
-
项目类别:
-
资助金额:$9.31万
-
财政年份:--
-
负责人:Arthur Sherman
-
依托单位:
Stimulus secretion coupling in pancreatic beta-cells
-
批准号:8741339
-
项目类别:
-
资助金额:$21.82万
-
财政年份:--
-
负责人:Arthur Sherman
-
依托单位:
Stimulus secretion coupling in pancreatic beta-cells
-
批准号:10697712
-
项目类别:
-
资助金额:$12.74万
-
财政年份:--
-
负责人:Arthur Sherman
-
依托单位:
Modeling Pathogenesis of Type 2 Diabetes
-
批准号:10697849
-
项目类别:
-
资助金额:$10.19万
-
财政年份:--
-
负责人:Arthur Sherman
-
依托单位:
Molecular modeling of G protein-coupled receptors
-
批准号:7733946
-
项目类别:
-
资助金额:$29.72万
-
财政年份:--
-
负责人:Arthur Sherman
-
依托单位:
海外基金